Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Radial Percutaneous Coronary Intervention in Complex Arm and Chest Vasculature: Tips and Tricks.

Parikh DS, Gandhi K, Shroff A.

Curr Treat Options Cardiovasc Med. 2019 Jan 26;21(1):2. doi: 10.1007/s11936-019-0707-6. Review.

PMID:
30685799
2.

Contemporary transradial access practices: Results of the second international survey.

Shroff AR, Fernandez C, Vidovich MI, Rao SV, Cowley M, Bertrand OF, Patel TM, Pancholy SB.

Catheter Cardiovasc Interv. 2018 Nov 19. doi: 10.1002/ccd.27989. [Epub ahead of print]

PMID:
30456913
3.

Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions.

Seto AH, Shroff A, Abu-Fadel M, Blankenship JC, Boudoulas KD, Cigarroa JE, Dehmer GJ, Feldman DN, Kolansky DM, Lata K, Swaminathan RV, Rao SV.

Catheter Cardiovasc Interv. 2018 Oct 1;92(4):717-731. doi: 10.1002/ccd.27637. Epub 2018 Apr 24.

PMID:
29691963
4.

Compartment Syndrome of the Hand: A Rare Sequela of Transradial Cardiac Catheterization.

Jue J, Karam JA, Mejia A, Shroff A.

Tex Heart Inst J. 2017 Feb 1;44(1):73-76. doi: 10.14503/THIJ-16-5795. eCollection 2017 Feb.

5.

Image noise reduction technology reduces radiation in a radial-first cardiac catheterization laboratory.

Gunja A, Pandey Y, Xie H, Wolska BM, Shroff AR, Ardati AK, Vidovich MI.

Cardiovasc Revasc Med. 2017 Apr - May;18(3):197-201. doi: 10.1016/j.carrev.2016.12.017. Epub 2016 Dec 27.

PMID:
28089778
6.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

7.

Patient-Centered Tablet Application for Improving Medication Adherence after a Drug-Eluting Stent.

Shah V, Dileep A, Dickens C, Groo V, Welland B, Field J, Baumann M, Flores JD, Shroff A, Zhao Z, Yao Y, Wilkie DJ, Boyd AD.

Front Public Health. 2016 Dec 12;4:272. doi: 10.3389/fpubh.2016.00272. eCollection 2016.

8.

Same-Day Discharge After Percutaneous Coronary Intervention-Reply.

Shroff A, Gilchrist IC, Rao SV.

JAMA Cardiol. 2016 Dec 1;1(9):1080. doi: 10.1001/jamacardio.2016.3370. No abstract available.

PMID:
27706465
9.

Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Kirtane AJ, Doshi D, Leon MB, Lasala JM, Ohman EM, O'Neill WW, Shroff A, Cohen MG, Palacios IF, Beohar N, Uriel N, Kapur NK, Karmpaliotis D, Lombardi W, Dangas GD, Parikh MA, Stone GW, Moses JW.

Circulation. 2016 Aug 2;134(5):422-31. doi: 10.1161/CIRCULATIONAHA.116.022061.

PMID:
27482004
10.

Same-Day Discharge After Percutaneous Coronary Intervention: Current Perspectives and Strategies for Implementation.

Shroff A, Kupfer J, Gilchrist IC, Caputo R, Speiser B, Bertrand OF, Pancholy SB, Rao SV.

JAMA Cardiol. 2016 May 1;1(2):216-23. doi: 10.1001/jamacardio.2016.0148. Review.

PMID:
27437896
11.

Compared to femoral venous access, upper extremity right heart catheterization reduces time to ambulation: A single center experience.

Speiser B, Pearson K, Xie H, Shroff AR, Vidovich MI.

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):658-664. doi: 10.1002/ccd.26573. Epub 2016 May 19.

PMID:
27193695
12.

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L; DAPT Study Investigators.

JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775. Erratum in: JAMA. 2016 Jul 19;316(3):350. Erratum in: JAMA. 2016 Jul 19;316(3):350.

13.

Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry.

Sandhu A, McCoy LA, Negi SI, Hameed I, Atri P, Al'Aref SJ, Curtis J, McNulty E, Anderson HV, Shroff A, Menegus M, Swaminathan RV, Gurm H, Messenger J, Wang T, Bradley SM.

Circulation. 2015 Sep 29;132(13):1243-51. doi: 10.1161/CIRCULATIONAHA.114.014451. Epub 2015 Aug 18.

PMID:
26286905
14.

My Interventional Drug-Eluting Stent Educational App (MyIDEA): Patient-Centered Design Methodology.

Boyd AD, Moores K, Shah V, Sadhu E, Shroff A, Groo V, Dickens C, Field J, Baumann M, Welland B, Gutowski G, Flores JD Jr, Zhao Z, Bahroos N, Hynes DM, Wilkie DJ.

JMIR Mhealth Uhealth. 2015 Jul 2;3(3):e74. doi: 10.2196/mhealth.4021.

16.

Aortic dissection and mortality associated with pregnancy in the United States.

Sawlani N, Shroff A, Vidovich MI.

J Am Coll Cardiol. 2015 Apr 21;65(15):1600-1. doi: 10.1016/j.jacc.2014.12.066. No abstract available.

17.

Complications of Transradial Cardiac Catheterization and Management.

Arora V, Patel M, Shroff AR.

Interv Cardiol Clin. 2015 Apr;4(2):193-202. doi: 10.1016/j.iccl.2014.12.004. Epub 2015 Mar 31. Review.

PMID:
28582050
18.

Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; Dual Antiplatelet Therapy (DAPT) Study Investigators.

JAMA. 2015 Mar 17;313(11):1113-21. doi: 10.1001/jama.2015.1671. Erratum in: JAMA. 2016 Jul 5;316(1):105. JAMA. 2016 Jul 5;316(1):105. JAMA. 2015 Jun 2;313(21):2185.

19.

Radiation safety and vascular access: attitudes among cardiologists worldwide.

Vidovich MI, Khan AA, Xie H, Shroff AR.

Cardiovasc Revasc Med. 2015 Mar;16(2):109-15. doi: 10.1016/j.carrev.2015.01.005. Epub 2015 Jan 29.

PMID:
25669957
20.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators.

N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.

Supplemental Content

Loading ...
Support Center